Pentostatin in steroid refractory acute graft versus host disease.

被引：0
|
作者：
Jacobsohn, D [1 ]
Margolis, J [1 ]
Anders, V [1 ]
Phelps, M [1 ]
Grever, M [1 ]
Vogelsang, G [1 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bone Marrow Transplant Program, Baltimore, MD 21218 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1628
引用
收藏
页码：420A / 420A
页数：1
相关论文
共 50 条
  • [21] Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease.
    Couriel, DR
    Hicks, K
    Saliba, R
    Cohen, A
    Ippoliti, C
    Donato, M
    Anderlini, P
    Giralt, S
    Khouri, I
    Hosing, C
    de Lima, M
    Andersson, B
    Neumann, J
    Champlin, R
    BLOOD, 2002, 100 (11) : 847A - 847A
  • [22] Efficacy of Etanercept in patients with steroid refractory acute graft versus host disease
    Ma, Chun Kei Kris
    Garcia-Cadenas, Irene
    Fox, Laura
    Ai, Sylvia
    Nivison-Smith, Ian
    Milliken, Samuel Thomas
    Dodds, Anthony
    Fay, Keith
    Ma, David D. F.
    Martino, Rodrigo
    Sierra, Jorge
    Moore, John
    BONE MARROW TRANSPLANTATION, 2018, 53 : 412 - 413
  • [23] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [24] Novel Drugs in the Treatment of Steroid Refractory Acute Graft Versus Host Disease
    Kovalenko, Iuliia
    Saleem, Tabinda
    Laek, Babray
    Ali, Rimsha
    Mirza, Taaha
    Chattaraj, Asmi
    Wahab, Ahsan
    Tameez, Asma
    Qurashi, Hafiz
    Golubykh, Konstantin
    Cuevas, Martin
    Ng, Wern Lynn
    Wert, Yijin
    Khan, Rafiullah
    BLOOD, 2022, 140 : 12895 - 12896
  • [25] ETANERCEPT FOR STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE: THE SCOTTISH EXPERIENCE
    Clark, D.
    Copland, A.
    McQuaker, I.
    Parker, N.
    Nicholson, A.
    HAEMATOLOGICA, 2012, 97 : 404 - 405
  • [26] Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease
    Pidala, Joseph
    Kim, Jongphil
    Roman-Diaz, Jaime
    Shapiro, Jamie
    Nishihori, Taiga
    Bookout, Ryan
    Anasetti, Claudio
    Kharfan-Dabaja, Mohamed A.
    ANNALS OF TRANSPLANTATION, 2010, 15 (04) : 21 - 29
  • [27] Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Ming J. Poi
    Craig C. Hofmeister
    Jeffrey S. Johnston
    Ryan B. Edwards
    Buffy S. Jansak
    David M. Lucas
    Sherif S. Farag
    James T. Dalton
    Steven M. Devine
    Michael R. Grever
    Mitch A. Phelps
    Clinical Pharmacokinetics, 2013, 52 : 705 - 712
  • [28] Ten years single center experience on pentostatin as salvage therapy of steroid refractory acute graft versus host disease of the GI-tract
    Klein, S. A.
    Bug, G.
    Mousset, S.
    W-K, Hofmann
    Martin, H.
    ONKOLOGIE, 2010, 33 : 162 - 162
  • [29] Long-term outcome of patients with severe steroid refractory acute intestinal graft-versus-host disease after treatment with pentostatin
    Klein, S. A.
    Bug, G.
    Mousset, S.
    Hofmann, W. -K.
    Martin, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S119 - S119
  • [30] Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Poi, Ming J.
    Hofmeister, Craig C.
    Johnston, Jeffrey S.
    Edwards, Ryan B.
    Jansak, Buffy S.
    Lucas, David M.
    Farag, Sherif S.
    Dalton, James T.
    Devine, Steven M.
    Grever, Michael R.
    Phelps, Mitch A.
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 705 - 712
12345